This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Information Update - Health Canada Suspends All Medical Device Licences Associated With IND Diagnostic

OTTAWA, Feb. 8, 2013 /CNW/ - Health Canada today suspended all medical device licences issued to and associated with IND Diagnostic of Delta, B.C., under its powers in the Food and Drugs Act, because of concerns about the company's management systems and distribution practices. The suspension means the devices can no longer be legally sold in Canada by any person. Health Canada's decision to suspend these licences is not based on an identified issue with the safety and effectiveness of any particular device.

The devices whose licences were suspended were sold directly by IND Diagnostic or by one of 13 private label manufacturers. The private label manufacturers are companies that purchased IND Diagnostic products and sold them under other names.

The devices include test kits used in pregnancy and ovulation, screening for blood in stool, urinary tract infections, infectious disease and illicit drugs. Some of the tests were sold in retail outlets, including discount/dollar stores for home use, while others were only sold for use by health professionals or laboratories.

Should patients or health professionals wish to confirm previous test results, there are authorized alternatives available in Canada for all the test kits whose licences have been suspended.

In addition to the concerns about IND Diagnostic's management system for licenced devices, Health Canada found the company was importing unlicensed medical devices mainly for export to other countries. Health Canada is not aware of these unlicensed devices being distributed to the Canadian public or the health care system. When Health Canada discovered this situation, it notified its international health partners and the Canada Border Services Agency to help ensure the devices were no longer being imported. IND Diagnostic has voluntarily recalled these unlicensed devices.

Health Canada is continuing to monitor this situation. If the Department is made aware of ongoing sales of products whose licences have been suspended, it will consider taking further action as warranted. Complaints about medical devices can be reported to the Health Products and Food Branch Inspectorate by calling the toll-free hotline at 1-800-267-9675, or by writing to:

Health Products and Food Branch Inspectorate Health Canada Address Locator: 2003D Ottawa, Ontario K1A 0K9

SOURCE Health Canada

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs